Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Bessis

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
JAMA Dermatology|September 15, 2021
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS TrialAnnabel Maruani, Elsa Tavernier, Olivia Boccara, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 25, 2024
Long-term effects of sirolimus treatment for slow-flow vascular malformations: Real-world evidence from the French observational multicentre SIROLO studyCécilia Maillet, Olivia Boccara, Stéphanie Mallet, et al.
Trials|December 19, 2019
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trialSophie Leducq, Agnès Caille, Sébastien Barbarot, et al.
JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.
The British Journal of Dermatology|August 16, 2022
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic responseDidier Bessis, Sophie Trouillet-Assant, Léo-Paul Secco, et al.
Journal of the American Academy of Dermatology|October 16, 2016
The scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literatureDidier Bessis, Michèle Bigorre, Nausicaa Malissen, et al.
Orphanet Journal of Rare Diseases|March 24, 2016
Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencingNadège Calmels, Géraldine Greff, Cathy Obringer, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
The Journal of Investigative Dermatology|March 7, 2020
Low Prevalence of GSC Gene Mutations in a Large Cohort of Predominantly Caucasian Patients with Hidradenitis SuppurativaSabine Duchatelet, Snaigune Miskinyte, Maia Delage, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2024
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patientsDidier Bessis, Anne-Claire Bursztejn, Fanny Morice-Picard, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
JAMA Dermatology|September 15, 2021
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS TrialAnnabel Maruani, Elsa Tavernier, Olivia Boccara, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 25, 2024
Long-term effects of sirolimus treatment for slow-flow vascular malformations: Real-world evidence from the French observational multicentre SIROLO studyCécilia Maillet, Olivia Boccara, Stéphanie Mallet, et al.
Trials|December 19, 2019
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trialSophie Leducq, Agnès Caille, Sébastien Barbarot, et al.
JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.
The British Journal of Dermatology|August 16, 2022
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic responseDidier Bessis, Sophie Trouillet-Assant, Léo-Paul Secco, et al.
Journal of the American Academy of Dermatology|October 16, 2016
The scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literatureDidier Bessis, Michèle Bigorre, Nausicaa Malissen, et al.
Orphanet Journal of Rare Diseases|March 24, 2016
Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencingNadège Calmels, Géraldine Greff, Cathy Obringer, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
The Journal of Investigative Dermatology|March 7, 2020
Low Prevalence of GSC Gene Mutations in a Large Cohort of Predominantly Caucasian Patients with Hidradenitis SuppurativaSabine Duchatelet, Snaigune Miskinyte, Maia Delage, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2024
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patientsDidier Bessis, Anne-Claire Bursztejn, Fanny Morice-Picard, et al.
Pageof 17